Shenzhen Uni-medica Technology Co., Ltd. announced that it will receive CNY 20 million in an equity round of funding through capital increase from new investor Beijing Leadman Biochemistry Co.,Ltd. to acquire 3.5088% stake in the company on November 8, 2022. The company has signed the capital increase agreement with investor. The CNY 308,277 will go to the registered capital and the rest CNY 19,691,723 will go to capital reverse.

The registered capital will change from CNY 8.477614 million to CNY 8.785891 million. The transaction has been approved at eighth meeting of the fifth board of directors of the Beijing Leadman Biochemistry Co.,Ltd.